CoChat

Paroxetine for the prevention of depression induced by high-dose interferon alfa.

Open access

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Depression commonly complicates treatment with the cytokine interferon alfa-2b. Laboratory animals pretreated with antidepressants have less severe depression-like symptoms after the administration of a cytokine. We sought to determine whether a similar strategy would be effective in humans. METHODS: In a double-blind study of 40 patients with malignant melanoma who were eligible for high-dose interferon alfa therapy, we randomly assigned 20 patients to receive the antidepressant paroxetine and 20 to receive placebo. The treatment was begun 2 weeks before the initiation of interferon alfa and continued for the first 12 weeks of interferon alfa therapy. RESULTS: During the first 12 weeks of interferon alfa therapy, symptoms consistent with a diagnosis of major depression developed in 2 of 18 patients in the paroxetine group (11 percent) and 9 of 20 patients in the placebo group (45 percent) (relative risk, 0.24; 95 percent confidence interval, 0.08 to 0.93). Severe depression necessitated the discontinuation of interferon alfa before 12 weeks in 1 of the 20 patients in the paroxetine group (5 percent), as compared with 7 patients in the placebo group (35 percent) (relative risk, 0.14; 95 percent confidence interval, 0.05 to 0.85). The incidence of adverse events was similar in the two groups. CONCLUSIONS: In patients with malignant melanoma, pretreatment with paroxetine appears to be an effective strategy for minimizing depression induced by interferon alfa.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm200103293441303

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 33 references

Research works printed but not linked: 7

  1. Borden EC, 1998, Semin Oncol, 25, 3
  2. Valentine AD, 1998, Semin Oncol, 25, 39
  3. Yamano M, 2000, J Pharmacol Exp Ther, 292, 181
  4. Winer BJ. Statistical principles in experiment design. 2nd ed. New York: McGraw-Hill, 1971.
  5. Levenson JL, 1993, Am J Gastroenterol, 88, 760
  6. Taylor JL, 1998, Semin Oncol, 25, 23
  7. Licinio J, 1998, Semin Oncol, 25, 30

Cited by

See all 1,120

Metadata

Authors
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H.
Affiliations
Emory University (US)
Venue
New England Journal of Medicine
Published
2001-03-29
Volume
344
Issue
13
Pages
961-966
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2338816059
Cited by
1,120
References
33
Citations by year
2026: 8 · 2025: 14 · 2024: 20 · 2023: 14 · 2022: 22 · 2021: 45 · 2020: 28 · 2019: 23 · 2018: 28 · 2017: 32 · 2016: 42 · 2015: 49 · 2014: 47 · 2013: 65 · 2012: 63
FWCI
40.29
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Emory University
  • Winship Cancer Institute
  • National Institute of Mental Health (MH-00680, MH 60723, R01MH060723)
  • National Center for Research Resources (MO1-RR30039)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
paroxetine, interferon alfa-2b, depression prevention, melanoma, high-dose interferon therapy, adverse events
MeSH terms
Interferon alpha-2, Adult, Aged, Antineoplastic Agents, Depressive Disorder, Double-Blind Method, Female, Humans, Male, Melanoma, Middle Aged, Recombinant Proteins, Interferon-alpha, Selective Serotonin Reuptake Inhibitors, Paroxetine, Disease-Free Survival, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Paroxetine for the prevention of depression induced by high-dose interferon alfa. https://app.cochat.ai/papers/10.1056/nejm200103293441303
The paper
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine. https://doi.org/10.1056/nejm200103293441303

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.